See also this year's filing and all EDGAR filings for this company.
PDF Report 0000792977_2016_AMAG_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000792977, AMAG Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 606,674,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,835,959,000 |
| 2 | PropertyPlantAndEquipmentNet | 28,725,000 |
| 3 | remainder_Assets | 16,074,000 |
| 4 | LiabilitiesCurrent | 245,921,000 |
| 5 | LiabilitiesNoncurrent | 3,777,000 |
| 6 | remainder_Liabilities | 1,305,470,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 159,734,339 |
| 9 | ResearchAndDevelopmentExpense | 45,393,118 |
| 10 | remainder_Expenses | 506,217,906 |
| 11 | remainder_Revenues | 1,884,262,659 |
| 12 | remainder_NetIncome | -425,262,201 |
| 13 | remainder_ComprehensiveNetIncome | 137,351,694 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,487,432,000 |
| 1 | Liabilities | 1,555,168,000 |
| 2 | Expenses | 711,345,363 |
| 3 | Revenues | 1,884,262,659 |
| 4 | StockholdersEquity | 932,264,000 |
| 5 | NetIncome | 747,655,095 |
| 6 | ComprehensiveNetIncome | 816,330,942 |
| 7 | BaseVar | 3,600,410,958 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.41 |
| 9 | EconomicCapitalRatio | 2.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
